United Therapeutics is making headway in unlocking a new lung disease market for its Tyvaso (treprostinil) with a pivotal ...

Obstructive lung disease -- of which Chronic Obstructive Pulmonary Disease is a type -- is marked by damage to lungs, causing ...

H.C. Wainwright on Tuesday raised its price target on MannKind to $11 from $9 and reiterated its buy rating on the shares, ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Pulmonary rehabilitation yields comparable benefits with minimal vs specialist gym exercise equipment in patients with ...

Chronic obstructive pulmonary disease, or COPD, is a group of lung diseases with no cure. CNN wellness expert Dr. Leana Wen ...

Imperative Care announced today that the FDA granted 510(k) clearance for its Symphony thrombectomy system to treat pulmonary embolism (PE).

Strategies that combine ferroptosis inhibition with established antifibrotics could ultimately move treatment from slowing progression to truly reversing fibrosis, new research suggests.

Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease characterised by the accumulation of scar tissue in the ...

Shares of United Therapeutics surged 37% to an all-time high on Tuesday after its drug Tyvaso significantly improved lung function in patients with a progressive lung condition in a late-stage study, ...

Without effective treatment, pulmonary arterial hypertension results in high morbidity and mortality. This review discusses the pathogenesis of the disorder, the thorough clinical evaluation requir ...

Pulsed field ablation did not have superior efficacy to radiofrequency ablation in patients with drug-resistant paroxysmal (intermittent) atrial fibrillation, according to results from a late-breaking ...